No image in the catalogue
GLISTROMA
Therapy Area: Glioblastoma,Astrocytoma; TEMOZOLAMIDE 100 mg. CAP.: 100 mg.; TEMOZOLAMIDE 20 mg. CAP.: 20 mg.; TEMOZOLAMIDE 250 mg. CAP.: 250 mg.
About this product
Therapy Area: Glioblastoma,Astrocytoma TEMOZOLAMIDE 100 mg. CAP.: 100 mg. TEMOZOLAMIDE 20 mg. CAP.: 20 mg. TEMOZOLAMIDE 250 mg. CAP.: 250 mg.
1 specification table for this product
Sign in with a free buyer account to see the complete tables, every construction and grade.
No certificates on file for Alkem Laboratories Limited.
Alkem Laboratories Limited
- Location
- India
- US shipments
- 1 to 1 buyer since Jan 2, 2026
Contact the supplier
What are you looking for from Alkem Laboratories Limited?
Prefer a form? Submit an RFQ